Avantor, Inc. (AVTR) Revenue by Segment

Avantor revenue by segment at a glance

In Q2 fiscal 2026 (the quarter ended June 30, 2026), Avantor's largest business segment was VWR Distribution & Services, with $1.24 billion or 73% of revenue, up 2.7% from a year earlier. Next: Bioscience & Medtech Products (27%).

By product or service, Proprietary Materials and Consumables brought in 52% and Third Party Materials and Consumables brought in 48% of revenue in Q2 fiscal 2026.

The fastest-growing business segment from a year earlier was VWR Distribution & Services (+2.7%).

From company filings, in USD; latest quarter ended June 30, 2026; quarterly data from Q2 fiscal 2018.

Avantor, Inc.

AVTRHealthcare

United States

Healthcare

Revenue breakdown

Fiscal quarters, from company filings

Segments by quarter (USD)

Click a bar to see that period below. Striped bars are calculated fourth quarters; an empty slot means it could not be calculated on the same basis i

AmericasLaboratory SolutionsEuropeBioscience ProductionVWR Distribution & ServicesBioscience & Medtech ProductsAmea

Q2 FY26 breakdown

Fiscal quarter ended Jun 30, 2026

Item	Revenue	Share	vs year before	Trend
VWR Distribution & Services	USD 1.24B	73.3%	+2.7%
Bioscience & Medtech Products	USD 451.80M	26.7%	-5.1%

Sum of items USD 1.69B. Shares are of the items shown. Click an item with › to see its parts.

Also reported by:

All periods

Every item and period in one grid. Purple = calculated; "–" = not available.

Item	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24	Q4 FY23	Q3 FY23	Q2 FY23	Q1 FY23	Q4 FY22	Q3 FY22	Q2 FY22	Q1 FY22	Q4 FY21	Q3 FY21	Q2 FY21	Q1 FY21	Q4 FY20	Q3 FY20	Q2 FY20	Q1 FY20	Q4 FY19	Q3 FY19	Q2 FY19	Q1 FY19	Q4 FY18	Q3 FY18	Q2 FY18
Americas	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.1B	1.2B	1.1B	–	1.0B	1.1B	1.0B	–	950.5M	857.5M	899.1M	–	918.2M	925.5M	857.3M	–	912.9M	882.6M
Laboratory Solutions	–	–	1.1B	1.1B	–	–	1.1B	1.2B	1.2B	1.2B	–	1.2B	1.2B	1.2B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Europe	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	595.1M	623.8M	680.4M	–	674.7M	666.0M	650.4M	–	562.1M	521.0M	544.0M	–	501.1M	518.6M	542.1M	–	503.1M	518.1M
Bioscience Production	–	–	547.5M	527.3M	–	–	560.8M	542.9M	547.1M	522.7M	–	561.1M	550.1M	577.3M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
VWR Distribution & Services	1.2B	1.1B	–	–	1.2B	1.2B	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Bioscience & Medtech Products	451.8M	431.4M	–	–	475.9M	426.4M	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Amea	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	138.2M	130.1M	126.6M	–	114.6M	122.8M	100.0M	–	92.4M	100.2M	75.9M	–	84.5M	88.3M	80.7M	–	78.2M	77.2M

Avantor revenue by business segment, last 4 quarters

Business segment	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
VWR Distribution & Services	$1.2B	$1.2B	–	$1.2B	73%
Bioscience & Medtech Products	$451.8M	$431.4M	–	$475.9M	27%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Avantor revenue by product or service, last 4 quarters

Product or service	Q2 FY26	Q1 FY26	Q3 FY25	Q2 FY25	Share
Proprietary Materials and Consumables	$880.4M	$833.3M	$855.6M	$893.8M	52%
Third Party Materials and Consumables	$811.9M	$748.1M	$768.2M	$789.6M	48%

In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.

Questions and answers

What are Avantor's business segments?

VWR Distribution & Services and Bioscience & Medtech Products (as reported for Q2 fiscal 2026).

Which business segment makes the most money for Avantor?

VWR Distribution & Services: $1.24 billion, or 73% of revenue, in Q2 fiscal 2026.

What are Avantor's main products and services?

By revenue in Q2 fiscal 2026: Proprietary Materials and Consumables (52%) and Third Party Materials and Consumables (48%).

MoreAvantor stock overview Avantor financials Avantor executive team Avantor shareholders

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.